Inspire Medical Systems Stock Analysis

INSP Stock  USD 164.30  0.65  0.39%   
Inspire Medical Systems is undervalued with Real Value of 186.6 and Target Price of 239.6. The main objective of Inspire Medical stock analysis is to determine its intrinsic value, which is an estimate of what Inspire Medical Systems is worth, separate from its market price. There are two main types of Inspire Medical's stock analysis: fundamental analysis and technical analysis.
The Inspire Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Inspire Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Inspire Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Inspire Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company last dividend was issued on the January 9, 2008. Inspire Medical Systems had 1:10 split on the September 13, 2002. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Inspire Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 485 people. To learn more about Inspire Medical Systems call Timothy Herbert at (844) 672-4357 or check out https://www.inspiresleep.com.

Inspire Medical Quarterly Total Revenue

239.72 Million

Inspire Medical Systems Investment Alerts

Inspire Medical generated a negative expected return over the last 90 days
Inspire Medical has high historical volatility and very poor performance
Inspire Medical is unlikely to experience financial distress in the next 2 years
Over 98.0% of the company shares are owned by institutional investors
Latest headline from kalkinemedia.com: Disposition of 204 shares by Bryan Phillips of Inspire Medical at 189.99 subject to Rule 16b-3

Inspire Medical Systems Upcoming and Recent Events

6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Inspire Largest EPS Surprises

Earnings surprises can significantly impact Inspire Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-11-05
2019-09-30-0.41-0.340.0717 
2018-08-07
2018-06-30-0.51-0.430.0815 
2022-08-02
2022-06-30-0.62-0.530.0914 
View All Earnings Estimates

Inspire Medical Environmental, Social, and Governance (ESG) Scores

Inspire Medical's ESG score is a quantitative measure that evaluates Inspire Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Inspire Medical's operations that may have significant financial implications and affect Inspire Medical's stock price as well as guide investors towards more socially responsible investments.

Inspire Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Hhg Plc2024-12-31
567.3 K
Macquarie Group Ltd2024-12-31
537.6 K
Jpmorgan Chase & Co2024-12-31
519.5 K
Geode Capital Management, Llc2024-12-31
486.3 K
Artisan Partners Limited Partnership2024-12-31
450.2 K
Champlain Investment Partners, Llc2024-12-31
444.4 K
Aqr Capital Management Llc2024-12-31
438.8 K
Timessquare Capital Management, Llc2024-12-31
433.8 K
Frontier Capital Management Co Inc2024-12-31
418.9 K
Blackrock Inc2024-12-31
4.2 M
Vanguard Group Inc2024-12-31
3.3 M
Note, although Inspire Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Inspire Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.91 B.

Inspire Profitablity

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.07 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.07  0.07 
Return On Equity 0.08  0.08 

Management Efficiency

Inspire Medical Systems has return on total asset (ROA) of 0.0304 % which means that it generated a profit of $0.0304 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0848 %, meaning that it created $0.0848 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/26/2025, Return On Tangible Assets is likely to grow to 0.07. Also, Return On Capital Employed is likely to grow to 0.05. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 03/26/2025, Liabilities And Stockholders Equity is likely to grow to about 848.8 M, while Non Current Liabilities Total is likely to drop slightly above 24.2 M.
Last ReportedProjected for Next Year
Book Value Per Share 23.17  24.33 
Tangible Book Value Per Share 23.17  24.33 
Enterprise Value Over EBITDA 83.01  87.16 
Price Book Value Ratio 8.00  7.60 
Enterprise Value Multiple 83.01  87.16 
Price Fair Value 8.00  7.60 
Enterprise Value5.4 B5.7 B
Leadership at Inspire Medical emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Operating Margin
0.133
Profit Margin
0.0667
Beta
1.479
Return On Assets
0.0304
Return On Equity
0.0848

Technical Drivers

As of the 26th of March, Inspire Medical retains the Risk Adjusted Performance of (0.04), market risk adjusted performance of (0.17), and Standard Deviation of 3.24. Inspire Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Inspire Medical Systems Price Movement Analysis

Execute Study
The output start index for this execution was fifty-nine with a total number of output elements of two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Inspire Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Inspire Medical Systems. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Inspire Medical Systems Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Inspire Medical Outstanding Bonds

Inspire Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inspire Medical Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inspire bonds can be classified according to their maturity, which is the date when Inspire Medical Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Inspire Medical Predictive Daily Indicators

Inspire Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Inspire Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Inspire Medical Corporate Filings

18th of March 2025
Other Reports
ViewVerify
F4
5th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
25th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
24th of February 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
F4
18th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
13th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
12th of February 2025
Other Reports
ViewVerify
8K
10th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Inspire Medical Forecast Models

Inspire Medical's time-series forecasting models are one of many Inspire Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inspire Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Inspire Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Inspire Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inspire shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Inspire Medical. By using and applying Inspire Stock analysis, traders can create a robust methodology for identifying Inspire entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.07  0.08 
Operating Profit Margin 0.04  0.05 
Net Profit Margin 0.07  0.07 
Gross Profit Margin 0.85  0.65 

Current Inspire Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inspire analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Inspire analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
239.6Strong Buy16Odds
Inspire Medical Systems current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Inspire analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inspire stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inspire Medical Systems, talking to its executives and customers, or listening to Inspire conference calls.
Inspire Analyst Advice Details

Inspire Stock Analysis Indicators

Inspire Medical Systems stock analysis indicators help investors evaluate how Inspire Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Inspire Medical shares will generate the highest return on investment. By understating and applying Inspire Medical stock analysis, traders can identify Inspire Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow185.5 M
Common Stock Shares Outstanding30.5 M
Total Stockholder Equity689.7 M
Tax Provision4.9 M
Quarterly Earnings Growth Y O Y1.324
Property Plant And Equipment Net95.2 M
Cash And Short Term Investments445.5 M
Cash150.2 M
Accounts Payable38.7 M
Net Debt-120.1 M
50 Day M A179.7864
Total Current Liabilities88.5 M
Other Operating Expenses766.7 M
Non Current Assets Total177.6 M
Forward Price Earnings79.3651
Non Currrent Assets Other11.3 M
Stock Based Compensation116 M

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.